Literature DB >> 32837195

Current burden on healthcare systems in low- and middle-income countries: recommendations for emergency care of COVID-19.

Husnain Hamid1, Zubia Abid1, Attiya Amir1, Touseef Ur Rehman1, Waqas Akram1, Tooba Mehboob1.   

Abstract

Entities:  

Year:  2020        PMID: 32837195      PMCID: PMC7415010          DOI: 10.1007/s40267-020-00766-2

Source DB:  PubMed          Journal:  Drugs Ther Perspect        ISSN: 1172-0360


× No keyword cloud information.

Background

The coronavirus disease 2019 (COVID-19) pandemic has spread dramatically, thereby increasing the risk of becoming infected. The mortality and morbidity rates of COVID-19 continue to climb each day, putting healthcare systems and healthcare professionals/providers (HCPs) at risk. Currently, the healthcare systems of low- and middle-income countries (LMICs) are unable to cope with these extremely difficult circumstances [1]. Maintaining the safety of HCPs is a key component of every well-operated healthcare system. The COVID-19 pandemic has created a huge workload burden for HCPs, which may lead to exhaustion and mental distress because of factors such as sleep disturbance, increased and lengthy working hours, debilitating fatigue, and the fear of becoming infected and exposing their family members to this potentially lethal infection [2]. HCPs, currently the most treasured national resource in the fight against COVID-19, should be well-protected against this infection [3]. This commentary highlights the COVID-19 burden and current status of healthcare systems and HCPs in LMICs and proposes possible preventive measures to care for HCPs.

COVID-19-related morbidity/mortality in healthcare providers

HCPs are at greater risk of becoming infected than other individuals because of their direct professional interactions with patients with COVID-19. Significant COVID-19-related morbidity and mortality rates have been observed in HCPs. According to 8 May 2020 data, a scoping review stated that, of 3,912,156 patients with COVID-19, 152,888 (3.9%) were HCPs [4]. In addition, 1413 (0.5%) of 270,426 COVID-19-related deaths were in HCPs. These data suggest that, for every 100 HCPs infected, one died [4].

Current healthcare facilities in low- and middle-income countries

It is generally stated that individuals in LMICs are deprived of sufficient levels of healthcare and cannot access medical facilities in a timely manner [5]. Naz et al. [6] found that, on average, physicians at district hospitals in many LMICs spend 54 s per patient, and rural dispensaries take 37 s to dispense medicine to a patient. Competent physicians are encouraged to emphasize their duties in private clinics, whereas government-employed physicians have dual responsibilities in public hospitals and private clinics [6]. According to the World Health Organization (WHO), there is a global lack of ≈ 4.3 million HCPs, primarily in South Asia and Africa. These regions also have the highest burden of illness, exacerbated by a smaller healthcare workforce [7]. Generally, the need to reinforce healthcare services, to improve the ability to meet the range of healthcare requirements of communities, has become a top priority, especially, but not entirely, in LMICs. Nevertheless, the systemic investigations into the interaction between healthcare received and healthcare required that would inform policy makers is lacking [8].

Burden on healthcare systems during COVID-19

Developed countries have considerably more expertise in the management and analysis of patients with COVID-19 than do LMICs. LMICs will probably be overburdened by COVID-19 because of the lack of public awareness about preventive measures, expertise, infrastructure, and human resources as well as the poor financial status of the country. Hence, LMICs must give priority to science-based precautionary measures in the pre-disaster phase and science-based counseling and treatment during and after the pandemic [1]. Healthcare resources in LMICs will be overloaded by patients with COVID-19. They have already been overwhelmed by patients with HIV/AIDS, pneumonia, malaria, and tuberculosis and patients who require surgery [9]. As the COVID-19 pandemic spreads in LMICs, difficult decisions must be made regarding the allocation of available healthcare supplies—ranging from hospital beds and HCPs to personal protective equipment (PPE), diagnostic capacity, and critical care services—between COVID-19-specific requirements and other health facilities [10]. Considering that most HCPs are not able to work in remote areas, programs that include early COVID-19 testing of asymptomatic and/or vanguard HCPs is essential. Elevated healthcare costs, such as the price of some antiviral drugs, the scarcity of PPE such as N95 face masks, and the lack of ventilators and intensive care unit beds have revealed deficiencies in the provision of patient care [11]. Public and private healthcare structures differ with regard to patient load. Secondary and primary healthcare facilities, particularly those in rural and peri-urban locations, may have a relatively poor reputation, because of the lack of HCPs, general equipment, and medicines. Such unprofessional and non- or malfunctioning primary and secondary healthcare offices can have a ripple effect, as they can lead many patients to attend tertiary healthcare institutes, most of which are in major cities. These factors increase the burden on and limit the facilities of tertiary care centers and add to the frustrations and costs of patients and their families [12].

Recommendations

Prior to the COVID-19 pandemic, healthcare structures in LMICs faced significant challenges in the provision of affordable, universal, and high-quality care. These health organizations had restricted financial assets and were lacking HCPs and accessible medications [13]. The COVID-19 crisis resulted in considerable changes in healthcare structures globally, with LMICs experiencing important consequences [14]. In view of such circumstances, the governments of LMICs should increase spending on healthcare and ensure an adequate supply of PPE to HCPs to guarantee their protection and health [15]. The availability of masks, ventilators, testing services, drugs used in the treatment of COVID-19, and hospital beds should also be increased. The salaries of all HCPs might also be increased to motivate HCPs as they are working tirelessly. This will encourage positive HCP attitudes toward patient care. Ensuring that hospitals have facilities to treat patients and increased numbers of HCPs will ultimately decrease the burden on individual HCPs and increase the level of patient care. More HCPs should be recruited and their duties allocated in ways that allow them time to rest, especially if they start showing symptoms associated with COVID-19. Worldwide health programs, such as foreign aid and non-government organizations, should emphasize the provision of physical goods (equipment, medicine, and clinics) and physicians to work in “underserved” areas. Governments should also educate the public about COVID-19, its preventive measures and symptoms, and general supportive treatments that can be provided at home. This will prevent hospitals from being overburdened with mild cases of the disease and would reduce the workload and burnout faced by HCPs in the hospital setting.

Take-home messages

Emphasize the need for HCPs to remain safe during healthcare crises such as the COVID-19 pandemic. Promote collaboration between international organizations, governments of LMICs, and HCPs to ensure needs are met and preventive and safety measures are established. Encourage the community to take preventive measures to minimize the transmission of COVID-19 and, eventually, reduce the workload of HCPs.
  12 in total

1.  Access as a policy-relevant concept in low- and middle-income countries.

Authors:  Di McIntyre; Michael Thiede; Stephen Birch
Journal:  Health Econ Policy Law       Date:  2009-01-30

2.  Challenges Faced by Pakistani Healthcare System: Clinician's Perspective.

Authors:  Faran Khalid; Ahmed Nadeem Abbasi
Journal:  J Coll Physicians Surg Pak       Date:  2018-12       Impact factor: 0.711

Review 3.  Sleep: its importance and the effects of deprivation on surgeons and other healthcare professionals.

Authors:  D A Parry; R S Oeppen; M S A Amin; P A Brennan
Journal:  Br J Oral Maxillofac Surg       Date:  2018-08-30       Impact factor: 1.651

4.  Motivational determinants among physicians in Lahore, Pakistan.

Authors:  Ahmad Azam Malik; Shelby Suzanne Yamamoto; Aurélia Souares; Zeeshan Malik; Rainer Sauerborn
Journal:  BMC Health Serv Res       Date:  2010-07-09       Impact factor: 2.655

Review 5.  The quality of medical care in low-income countries: from providers to markets.

Authors:  Jishnu Das
Journal:  PLoS Med       Date:  2011-04-12       Impact factor: 11.069

6.  COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being.

Authors:  Bobak Moazzami; Niloofar Razavi-Khorasani; Arash Dooghaie Moghadam; Ermia Farokhi; Nima Rezaei
Journal:  J Clin Virol       Date:  2020-04-04       Impact factor: 3.168

7.  Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries.

Authors:  Irene A Kretchy; Michelle Asiedu-Danso; James-Paul Kretchy
Journal:  Res Social Adm Pharm       Date:  2020-04-15

8.  Emergency and essential surgical healthcare services during COVID-19 in low- and middle-income countries: A perspective.

Authors:  Xiya Ma; Dominique Vervoort; Ché L Reddy; Kee B Park; Emmanuel Makasa
Journal:  Int J Surg       Date:  2020-05-16       Impact factor: 6.071

Review 9.  To Protect Health Care Workers Better, To Save More Lives With COVID-19.

Authors:  Weiyun Chen; Yuguang Huang
Journal:  Anesth Analg       Date:  2020-07       Impact factor: 5.108

Review 10.  The COVID-19 Pandemic: Effects on Low- and Middle-Income Countries.

Authors:  Choon-Looi Bong; Christopher Brasher; Edson Chikumba; Robert McDougall; Jannicke Mellin-Olsen; Angela Enright
Journal:  Anesth Analg       Date:  2020-07       Impact factor: 5.108

View more
  5 in total

1.  Low expression of TMPRSS2-a SARS-CoV-2 internalization protease-associates with basal subtype of head and neck squamous cell carcinoma.

Authors:  Jayesh Tiwari; Nancy Tripathi; Ravi Shanker Srivastava; Sujeet Kumar; Sanjay Singh; Shreyans Jain; Arun Khattri
Journal:  Transl Oncol       Date:  2022-05-19       Impact factor: 4.803

2.  Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population: A global survey of 20 countries.

Authors:  Roy Rillera Marzo; Absar Ahmad; Md Saiful Islam; Mohammad Yasir Essar; Petra Heidler; Isabel King; Arulmani Thiyagarajan; Kittisak Jermsittiparsert; Karnjana Songwathana; Delan Ameen Younus; Radwa Abdullah El-Abasiri; Burcu Kucuk Bicer; Nhat Tan Pham; Titik Respati; Susan Fitriyana; Erwin Martinez Faller; Aries Moralidad Baldonado; Md Arif Billah; Yadanar Aung; Shehu Muhammad Hassan; Muhammad Mujtaba Asad; Kareem Ahmed El-Fass; Sudip Bhattacharya; Sunil Shrestha; Nouran Ameen Elsayed Hamza; Pascal Friedmann; Michael Head; Yulan Lin; Siyan Yi
Journal:  PLoS Negl Trop Dis       Date:  2022-01-28

3.  Enablers and hindrances to health promotion and disease prevention practices among healthcare workers in Nelson Mandela Bay Municipality, South Africa.

Authors:  Herbert I Melariri; Chester Kalinda; Moses J Chimbari
Journal:  Prev Med Rep       Date:  2021-06-22

4.  Comparative analysis of N95 respirators fit testing with commercially available and in house reagent.

Authors:  Erum Khan; Joveria Farooqi; Humaira Shafaq; Kaleem Ullah Khushik; Syed Shamim Raza; Sara Khan; Zohra Rafiq; Bushra Ahmed; Shazia Chisti; Kehkashan Imtiaz; Hasnain Zafar; Afia Zafar
Journal:  Infect Prev Pract       Date:  2021-01-15

5.  Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial.

Authors:  Pauline Byakika-Kibwika; Christine Sekaggya-Wiltshire; Jerome Roy Semakula; Jane Nakibuuka; Joseph Musaazi; James Kayima; Cornelius Sendagire; David Meya; Bruce Kirenga; Sarah Nanzigu; Arthur Kwizera; Fred Nakwagala; Ivan Kisuule; Misaki Wayengera; Henry G Mwebesa; Moses R Kamya; William Bazeyo
Journal:  BMC Infect Dis       Date:  2021-12-06       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.